Systematic analysis of coronary artery disease datasets revealed the potential biomarker and treatment target

Yan Shi1, Sijin Yang2, Man Luo3

  • 1Department of Emergency, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.

Oncotarget
|September 15, 2017
PubMed

Insights

Coronary artery disease (CAD) is a leading cause of death. This study identified nine key genes and immune response pathways, particularly neutrophil degranulation, linked to CAD through meta-analysis for early prevention strategies.

Area of Science:

  • Genomics and Bioinformatics
  • Cardiovascular Disease Research

Background:

  • Coronary artery disease (CAD) accounts for a significant portion of deaths in the United States.
  • Early prevention of CAD holds potential for reducing incidence and mortality.
  • Identifying genetic factors is crucial for understanding CAD pathogenesis.

Purpose of the Study:

  • To identify genes involved in coronary artery disease using a meta-analysis approach.
  • To explore the biological pathways associated with differentially expressed genes in CAD.
  • To analyze protein-protein interactions among identified candidate genes.

Main Methods:

  • Retrieved and preprocessed five coronary heart disease gene expression datasets from the GEO series.
  • Utilized moderated t-test for single-dataset differential gene expression analysis.
  • Performed meta-analysis using MetaDE for combined p-value calculation and pathway enrichment analysis with Reactome database.

Main Results:

  • A total of 238 cases and 189 controls from five microarray datasets were analyzed.
  • Nine differentially expressed genes (LFNG, ID3, PLA2G7, FOLR3, PADI4, ARG1, IL1R2, NFIL3, MGAM) were identified using a False Discovery Rate (FDR) cut-off of 0.1.
  • These genes exhibited close protein-protein interactions, and 24 Reactome pathways were found to be related to coronary artery disease.

Conclusions:

  • Immune response pathways, specifically neutrophil degranulation, are significantly associated with coronary heart disease.
  • The identified genes and pathways provide potential targets for early CAD prevention and therapeutic strategies.
  • Meta-analysis is a robust method for identifying genetic markers in complex diseases like CAD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
746
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
969
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
631
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
605